Tin tức & Cập nhật

Nelonemdaz safe but fails to improve outcomes in stroke
Nelonemdaz safe but fails to improve outcomes in stroke
01 Nov 2022

Treatment with nelonemdaz, a multitarget neuroprotectant that selectively blocks N-methyl-D-aspartate receptors and scavenges free radicals, does not appear to significantly improve stroke outcomes as compared with placebo, although nelonemdaz-treated patients show a greater tendency toward achieving modified Rankin Scale scores of 0–2 at 12 weeks, according to the results of a phase II study.

Nelonemdaz safe but fails to improve outcomes in stroke
01 Nov 2022
Psychotic disorders a potentially modifiable risk factor for dementia
Psychotic disorders a potentially modifiable risk factor for dementia
25 Oct 2022
Hypertension shows weak to no link to cognition in late life
Hypertension shows weak to no link to cognition in late life
13 Oct 2022
Early noninferior to delayed NOAC initiation after stroke in AF patients
Early noninferior to delayed NOAC initiation after stroke in AF patients
13 Oct 2022

Early initiation of nonvitamin K antagonist oral anticoagulants (NOACs) after acute ischaemic stroke in patients with atrial fibrillation (AF) appears to yield similar outcomes when compared with delayed initiation, as shown in the results of the TIMING* study.

Early noninferior to delayed NOAC initiation after stroke in AF patients
13 Oct 2022